Home
Stock Market News
Market Sentiment
Trending Industries
Blogs
Contact us
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials
Eli Lilly's Zepbound has outperformed Novo Nordisk's Wegovy in weight loss trials. Zepbound targets adults with obesity and comorbidities.